Slate Bio
Charlottesville
About Slate Bio
Slate Bio is an immunotherapeutics development company that develops therapies that restore the body's natural immunological response in different diseases using bifunctional IL233 cytokine, thereby providing users with an independent synergistic pathway that has greater tissue selectivity and improved pharmacodynamics.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $4.5M
- Last round: Series Unknown (Jan 2023)
- Website: slatebio.com
- Phone: (434) 989-6299
Industries & Categories
Biotechnology, Health Care, Medical, Therapeutics
Canonical: https://fsome.com/organization/slate-bio-3808 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.